Market Cap 144.79M
Revenue (ttm) 0.00
Net Income (ttm) -41.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 769,400
Avg Vol 2,188,948
Day's Range N/A - N/A
Shares Out 85.17M
Stochastic %K 65%
Beta 0.48
Analysts Strong Sell
Price Target $6.60

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collabora...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 336 0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
Stockseeking
Stockseeking Mar. 15 at 8:10 PM
$MIST “Some people with PSVT have endured years of anxiety, fearing their next episode and the stress and disruption of emergency department visits,” said James Ip, MD, FACC, FHRS, an etripamil investigator. “Cardamyst will give many of them the ability to administer a medication themselves that can quickly stop their PSVT episode and potentially avoid a hospital trip or a call to emergency service
0 · Reply
StockAuthority
StockAuthority Mar. 15 at 8:01 PM
$MIST $NIXX 1000% to 1500% sounds good to me, how about you!?
0 · Reply
MarketILF
MarketILF Mar. 15 at 12:35 PM
$MIST the jinx bold nurse spewing shit from his sorry mouth again on MIST
1 · Reply
Ga_glovo
Ga_glovo Mar. 15 at 11:34 AM
1 · Reply
Vincybull
Vincybull Mar. 15 at 10:22 AM
$MIST By the end of 2026 if cardamyst does what I think milestone will reach 15/20$
0 · Reply
AP1810
AP1810 Mar. 15 at 2:32 AM
$MIST Has anyone seen the Seeking Alpha article posted today? I don’t have access to it, but some nurse downgraded MIST to a sell.
3 · Reply
Bennyman369
Bennyman369 Mar. 14 at 7:10 PM
What is your best bets for a big gain of 300-400%+ for 2026 ? For my part, I took $MIST for a 4X potential And $NIXX for 10-15X+ potential
4 · Reply
Stockseeking
Stockseeking Mar. 13 at 10:35 PM
$MIST next week will be interesting. Looking forward to launch update. If not very positive, activist investors will push for a sale of the company. Prior to Friday, sp>1.85, after >2
0 · Reply
jap1511
jap1511 Mar. 13 at 5:56 PM
$MIST gem here. Took a starter and Hope it dips to 1.60 for another tranche
0 · Reply
Stockseeking
Stockseeking Mar. 13 at 5:01 PM
$MIST One product launched and one p3 ready based on the same mechanism of action and for a much bigger patient population. Market cap of only 150m. Compared to clinical phase companies, the risk is much lower with even bigger reward.
0 · Reply
Latest News on MIST
Milestone® Pharmaceuticals to Present at Upcoming Conferences

Aug 19, 2025, 8:00 AM EDT - 7 months ago

Milestone® Pharmaceuticals to Present at Upcoming Conferences


Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge

Jul 11, 2025, 2:37 PM EDT - 8 months ago

Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 8 months ago

Milestone Pharmaceuticals Announces Proposed Public Offering


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 1 year ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Stockseeking
Stockseeking Mar. 15 at 8:10 PM
$MIST “Some people with PSVT have endured years of anxiety, fearing their next episode and the stress and disruption of emergency department visits,” said James Ip, MD, FACC, FHRS, an etripamil investigator. “Cardamyst will give many of them the ability to administer a medication themselves that can quickly stop their PSVT episode and potentially avoid a hospital trip or a call to emergency service
0 · Reply
StockAuthority
StockAuthority Mar. 15 at 8:01 PM
$MIST $NIXX 1000% to 1500% sounds good to me, how about you!?
0 · Reply
MarketILF
MarketILF Mar. 15 at 12:35 PM
$MIST the jinx bold nurse spewing shit from his sorry mouth again on MIST
1 · Reply
Ga_glovo
Ga_glovo Mar. 15 at 11:34 AM
1 · Reply
Vincybull
Vincybull Mar. 15 at 10:22 AM
$MIST By the end of 2026 if cardamyst does what I think milestone will reach 15/20$
0 · Reply
AP1810
AP1810 Mar. 15 at 2:32 AM
$MIST Has anyone seen the Seeking Alpha article posted today? I don’t have access to it, but some nurse downgraded MIST to a sell.
3 · Reply
Bennyman369
Bennyman369 Mar. 14 at 7:10 PM
What is your best bets for a big gain of 300-400%+ for 2026 ? For my part, I took $MIST for a 4X potential And $NIXX for 10-15X+ potential
4 · Reply
Stockseeking
Stockseeking Mar. 13 at 10:35 PM
$MIST next week will be interesting. Looking forward to launch update. If not very positive, activist investors will push for a sale of the company. Prior to Friday, sp>1.85, after >2
0 · Reply
jap1511
jap1511 Mar. 13 at 5:56 PM
$MIST gem here. Took a starter and Hope it dips to 1.60 for another tranche
0 · Reply
Stockseeking
Stockseeking Mar. 13 at 5:01 PM
$MIST One product launched and one p3 ready based on the same mechanism of action and for a much bigger patient population. Market cap of only 150m. Compared to clinical phase companies, the risk is much lower with even bigger reward.
0 · Reply
Vincybull
Vincybull Mar. 13 at 4:52 PM
$MIST -7 days to 4Q25 and then we'll see each other in 60 days for 1Q2026 and then by August 10th for 2Q2026 the games are finished the product is on the market depends only on sales. If Cardamyst is successful in sales the stock will fly very very very high. The rest is just words.
1 · Reply
Ehri
Ehri Mar. 13 at 3:40 PM
$MIST Thanks!
0 · Reply
Diverstj981
Diverstj981 Mar. 13 at 2:32 PM
$MIST It'll be pretty sleepy here for the next week at least. Maybe even for the next 6 months depending on earnings, guidance, warrant status. Personally, I don't see any significant moves until Q3/Q4. Wish I was wrong, but I don't think so. Time to exercise patience and keep the mental demons in their cages. Long term bullish.
1 · Reply
Rock_Fan1
Rock_Fan1 Mar. 13 at 12:05 PM
$MIST There is a Facebook group of over 35,000 members. Superventricular Tachycardia Group, SVT. They are all over Cardamyst this morning. Talking about effectiveness, excitement about finally getting a scrip filled, ins coverage. One member participated in the trials and is biggest booster. Great stuff. Momentum is clearly building.
0 · Reply
equitiesrus
equitiesrus Mar. 13 at 11:21 AM
$MIST i dont know enough about this biotech investment but i hope it weathers the current macroeconomic conditions like it seemingly has these past few days, and becomes a safe haven and gets the SP to closer to analyst expectations soon!
0 · Reply
CurlyBear
CurlyBear Mar. 12 at 7:12 PM
$MIST last time to buy cheap
2 · Reply
Ga_glovo
Ga_glovo Mar. 12 at 6:27 PM
$MIST people what are talking about? There will be no sales in this report, it is 4Q25 period, also, RTW payment arrived in 1Q26, so cash positon will be either reduced but if warrants A are excercised it will be boosted - we will indeed see status of warranst in this report, perhaps some intial expectations and that is all - eranings call will be important due to questions as analysts will ask about coverage expansion, sales force activity and gudance for 1Q26 or 2Q26.
3 · Reply
klem817
klem817 Mar. 12 at 6:09 PM
$MIST company is bad for investor. it not makes any sale. product is not gain patient. more dilute is come
6 · Reply
CashisKing_
CashisKing_ Mar. 12 at 6:04 PM
0 · Reply
Stockseeking
Stockseeking Mar. 12 at 5:20 PM
$MIST I can only see positive coming out March 20th 1. Launch update-Cardamyst readily available 2. Cash position 3. China update
1 · Reply
Wide_Birth
Wide_Birth Mar. 12 at 3:06 PM
$MIST This coming earnings should confirm how much cash MIST had on-hand after their 75mil approval payment from RTW, and might shed some light on the number of warrants that were exercised between Nov. and Dec.
0 · Reply
Stockseeking
Stockseeking Mar. 12 at 2:09 PM
$MIST Cardamyst is widely available now. Guess we will hear something next Friday.
0 · Reply